Literature DB >> 6728125

Experimental convulsions in rats induced by intraventricular administration of kynurenine and structurally related compounds.

A Pinelli, C Ossi, R Colombo, O Tofanetti, L Spazzi.   

Abstract

Administration of L-kynurenine and some analogous molecules into the right lateral ventricle caused convulsive attacks in rats. These convulsions are tonic-clonic. Various modifications of the structure of L-kynurenine affected the production of convulsions. In particular, methylation of the carboxyl group increased the potency. Methylation of the carboxyl function and hydroxylation of the benzene ring greatly increased the latency and the duration of the convulsions. Removal of the carboxyl function or its reduction resulted in the loss of the epileptogenic effect. Masking of the amino function with formyl or acetyl residues also produced inactive compounds. The results of structural modification of the kynurenine carbon skeleton clearly show that the structure essential for stimulation of convulsive activity includes a free amino group and a free or masked carboxyl function. The molecular structure able to induce convulsive effects appears to be the laevo -isomer of kynurenine, since the dextro-form has been proved to be inactive. The convulsant activity, evaluated as the ED50, for L-kynurenine, is between that of bicuculline and pentamethylenetetrazole . The convulsant mechanism of kynurenine is unknown, but might very possibly involve interference with the activity of certain inhibitory neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728125     DOI: 10.1016/0028-3908(84)90196-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.

Authors:  W F Owen; J Petersen; D M Sheff; R D Folkerth; R J Anderson; J M Corson; A L Sheffer; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Regional changes in the concentrations of glutamate, glycine, taurine, and GABA in the vitamin B-6 deficient developing rat brain: association with neonatal seizures.

Authors:  T R Guilarte
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

3.  The role of hydrogen peroxide in the in vitro cytotoxicity of 3-hydroxykynurenine.

Authors:  C L Eastman; T R Guilarte
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

Review 4.  [The importance of vitamin B 6 for development of the infant. Human medical and animal experiment studies].

Authors:  H Gerster
Journal:  Z Ernahrungswiss       Date:  1996-12

5.  Convulsions and inhibition of glutamate decarboxylase by pyridoxal phosphate-gamma-glutamyl hydrazone in the developing rat.

Authors:  L Massieu; A Rivera; R Tapia
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

6.  The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain.

Authors:  H Kabuto; I Yokoi; M Takei; T Kurimoto; A Mori
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

7.  Antagonism of seizures induced by the administration of the endogenous convulsant quinolinic acid into rat brain ventricles.

Authors:  I P Lapin; I B Prakhie; I P Kiseleva
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 8.  Changing the face of kynurenines and neurotoxicity: therapeutic considerations.

Authors:  Zsuzsanna Bohár; József Toldi; Ferenc Fülöp; László Vécsei
Journal:  Int J Mol Sci       Date:  2015-04-29       Impact factor: 5.923

Review 9.  The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.

Authors:  Katarzyna Ciapała; Joanna Mika; Ewelina Rojewska
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.